As a patient, it’s so important to understand your condition. This is especially true for people with diabetes. Though diabetes has no known cure right now, you should be aware of the recent medical advances and discoveries as researchers work on finding a cure and improving treatments.
Having access to up-to-date news about diabetes research is one of the best ways to become an educated patient. That’s why we’ll update you with weekly research and treatment information, so that you can take the best care of your diabetes, whether it’s type 1, type 2, or gestational.
The goal is to make you an informed person who can talk with ease about diabetes, not just with relatives and friends but also with your doctor. The more you know, the more involved you can be in your healthcare decisions.
- Continuous Glucose Monitoring helps those with type 1 diabetes who inject insulin with blood sugar control, better A1C, research shows.
- A new study has found that black tea significantly reduces rises in blood glucose levels among both healthy and pre-diabetic adults, in this case after consuming a sugary drink.
- Women treated for subclinical hypothyroidism (SCH) during pregnancy are less likely to experience pregnancy loss, a new study shows, but they face a greater risk of complications such as preterm delivery, gestational diabetes and pre-eclampsia.
- The diabetes drug empagliflozin (Jardiance) is now a ''double duty'' drug. It can be prescribed not only to help treat diabetes, but also to reduce the risk of cardiovascular death in adults diagnosed with both type 2 diabetes and cardiovascular disease.
- If you're diagnosed with gestational diabetes, the type that occurs during pregnancy, you may also be at an increased risk for developing postpartum depression, according to a new study that tracked more than 700,000 women.
- Users of the Dexcom G5 Mobile Continuous Glucose Monitoring System (Dexcom G5) can now use the device to make diabetes treatment decisions with two finger pricks daily, not multiple ones, following .
- A review of various dietary sugar guidelines has found that recommendations on how much sugar one should consume in a day vary widely and are based on low to very low quality evidence, according to new research published in the Annals of Internal Medicine.
- A new study finds that lifestyle habits, not genetics, is the bigger driver affecting how much fat you can accumulate in the pancreas.
- A new study published in the journal Cancer Research found that high body mass index (BMI) and a large waist circumference were associated with an increased risk for liver cancer.
- People with prediabetes and low thyroid function were more than twice as likely to progress to full-blown type 2 diabetes compared to those with normal thyroid-hormone levels in a new study published September 30 in the journal BMC Medicine.
- More than 100,000 U.S. and Canadian users of the OneTouch Ping Insulin pump learned this week that the pump's technology was hackable and could lead to an insulin overdose. A perspective on the real risk.
- The U.S. Food and Drug Administration (FDA) yesterday approved the MiniMed 670G, the first so-called “artificial pancreas” – a device that monitors blood sugar and automatically delivers personalized insulin doses to people with type 1 diabetes.
- Liraglutide (Victoza), a drug used to help control blood sugar levels in type 2 diabetes, also reduces the risk of dying from heart disease, new research suggests.
- When researchers from Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, checked the hearts and medical records of 9,498 people over nine years, they found nearly equal numbers of untreated, silent heart attacks and recognized heart attacks that had received medical attention.
- An animal study found that injecting a hormone directly into the brain of rodents put type 2 diabetes in remission for several months, reports the journal Nature Medicine.
- People with peripheral artery disease (PAD) – including many with diabetes – who took cholesterol-lowering statin drugs had a 22-33 percent lower risk of losing a leg or other limb to amputation in a new Emory University study.
- Women who have had pregnancy-related diabetes may be able to reduce their future risk of hypertension by maintaining a healthful diet, shows new research published in the journal Hypertension.
- A higher-dose version of a diabetes medication liraglutide improves weight loss and reverses prediabetes in a new study.
- Dexcom, Inc., one of the largest makers of continuous glucose monitoring systems (CGMs) in the U.S. is recalling receivers for its G4 Platinum and G5 Mobile CGM systems because of consumer complaints that alarms for low and high blood sugar levels may not sound.
- A new study reveals strong evidence that pioglitazone does in fact increase the risk of bladder cancer, and that the increased risk can occur as quickly as about 22 months on the drug.
- People with type 2 diabetes who use insulin saw out-of-pocket expenses triple between 2002 and 2013, according to a new study published in the Journal of the American Medical Association.
- The first biosimilar, a less expensive copy of the popular, long-acting brand-name drug Lantus, is set to hit U.S. pharmacy shelves later this year.
- Having an excess of the hormone leptin while pregnant could be one of the reasons why children born to obese women are at a higher risk of type 2 diabetes, cites a new study in the journal Cell Reports.
- Long-term use of the popular diabetes drug metformin is linked with vitamin B12 deficiency and anemia, according to new research that solidifies some previous research.
- A new study published in the journal Metabolism found that obesity and type 2 diabetes led to weakened bones.